GH Research plans to provide an update on the status of its investigational new drug application for GH001, a therapy for treatment-resistant depression.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback